Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

Based on Intelligencia AI’s comprehensive, proprietary database of over 20,000 industry-sponsored, interventional oncology clinical programs (around 12,400 clinical trials), recent insights highlight ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

Scientists have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building blocks that influence how drugs interact with the body.

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

BullFrog AI plans to introduce what it considers a game-changing approach that could shorten timelines, reduce costs, and increase success rates in drug development.

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS' Saint-Beauzire site ...